These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
270 related articles for article (PubMed ID: 26367347)
21. Binding of hnRNP H and U2AF65 to respective G-codes and a poly-uridine tract collaborate in the N50-5'ss selection of the REST N exon in H69 cells. Ortuño-Pineda C; Galindo-Rosales JM; Calderón-Salinas JV; Villegas-Sepúlveda N; Saucedo-Cárdenas O; De Nova-Ocampo M; Valdés J PLoS One; 2012; 7(7):e40315. PubMed ID: 22792276 [TBL] [Abstract][Full Text] [Related]
22. HER2-PI9 and HER2-I12: two novel and functionally active splice variants of the oncogene HER2 in breast cancer. Hart V; Silipo M; Satam S; Gautrey H; Kirby J; Tyson-Capper A J Cancer Res Clin Oncol; 2021 Oct; 147(10):2893-2912. PubMed ID: 34136934 [TBL] [Abstract][Full Text] [Related]
23. hnRNP F directs formation of an exon 4 minus variant of tumor-associated NADH oxidase (ENOX2). Tang X; Kane VD; Morré DM; Morré DJ Mol Cell Biochem; 2011 Nov; 357(1-2):55-63. PubMed ID: 21625959 [TBL] [Abstract][Full Text] [Related]
24. Nuclear ARVCF protein binds splicing factors and contributes to the regulation of alternative splicing. Rappe U; Schlechter T; Aschoff M; Hotz-Wagenblatt A; Hofmann I J Biol Chem; 2014 May; 289(18):12421-34. PubMed ID: 24644279 [TBL] [Abstract][Full Text] [Related]
25. hnRNP H and hnRNP F complex with Fox2 to silence fibroblast growth factor receptor 2 exon IIIc. Mauger DM; Lin C; Garcia-Blanco MA Mol Cell Biol; 2008 Sep; 28(17):5403-19. PubMed ID: 18573884 [TBL] [Abstract][Full Text] [Related]
26. Heterogenous Nuclear Ribonucleoprotein H1 Promotes Colorectal Cancer Progression through the Stabilization of mRNA of Sphingosine-1-Phosphate Lyase 1. Takahashi K; Fujiya M; Konishi H; Murakami Y; Iwama T; Sasaki T; Kunogi T; Sakatani A; Ando K; Ueno N; Kashima S; Moriichi K; Tanabe H; Okumura T Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32630435 [TBL] [Abstract][Full Text] [Related]
27. PTBP1 and PTBP2 impaired autoregulation of SRSF3 in cancer cells. Guo J; Jia J; Jia R Sci Rep; 2015 Sep; 5():14548. PubMed ID: 26416554 [TBL] [Abstract][Full Text] [Related]
28. A genome landscape of SRSF3-regulated splicing events and gene expression in human osteosarcoma U2OS cells. Ajiro M; Jia R; Yang Y; Zhu J; Zheng ZM Nucleic Acids Res; 2016 Feb; 44(4):1854-70. PubMed ID: 26704980 [TBL] [Abstract][Full Text] [Related]
29. CD44 alternative splicing and hnRNP A1 expression are associated with the metastasis of breast cancer. Loh TJ; Moon H; Cho S; Jang H; Liu YC; Tai H; Jung DW; Williams DR; Kim HR; Shin MG; Liao DJ; Zhou J; Shi W; Zheng X; Shen H Oncol Rep; 2015 Sep; 34(3):1231-8. PubMed ID: 26151392 [TBL] [Abstract][Full Text] [Related]
30. Interaction of muscleblind, CUG-BP1 and hnRNP H proteins in DM1-associated aberrant IR splicing. Paul S; Dansithong W; Kim D; Rossi J; Webster NJ; Comai L; Reddy S EMBO J; 2006 Sep; 25(18):4271-83. PubMed ID: 16946708 [TBL] [Abstract][Full Text] [Related]
31. Downregulation of SRSF3 by antisense oligonucleotides sensitizes oral squamous cell carcinoma and breast cancer cells to paclitaxel treatment. Sun Y; Yan L; Guo J; Shao J; Jia R Cancer Chemother Pharmacol; 2019 Nov; 84(5):1133-1143. PubMed ID: 31515668 [TBL] [Abstract][Full Text] [Related]
32. High-throughput analyses of hnRNP H1 dissects its multi-functional aspect. Uren PJ; Bahrami-Samani E; de Araujo PR; Vogel C; Qiao M; Burns SC; Smith AD; Penalva LO RNA Biol; 2016; 13(4):400-11. PubMed ID: 26760575 [TBL] [Abstract][Full Text] [Related]
33. Poison-Exon Inclusion in DHX9 Reduces Its Expression and Sensitizes Ewing Sarcoma Cells to Chemotherapeutic Treatment. Palombo R; Verdile V; Paronetto MP Cells; 2020 Jan; 9(2):. PubMed ID: 32023846 [TBL] [Abstract][Full Text] [Related]
34. Splicing factor SRSF3 promotes the progression of cervical cancer through regulating DDX5. Che Y; Bai M; Lu K; Fu L Mol Carcinog; 2023 Feb; 62(2):210-223. PubMed ID: 36282044 [TBL] [Abstract][Full Text] [Related]
36. MicroRNA-1908-5p contributes to the oncogenic function of the splicing factor SRSF3. Kim HR; Shin CH; Lee H; Choi KH; Nam DH; Ohn T; Kim HH Oncotarget; 2017 Jan; 8(5):8342-8355. PubMed ID: 28039456 [TBL] [Abstract][Full Text] [Related]
37. Loss of TDP43 inhibits progression of triple-negative breast cancer in coordination with SRSF3. Ke H; Zhao L; Zhang H; Feng X; Xu H; Hao J; Wang S; Yang Q; Zou L; Su X; Wang L; Wu C; Wang Y; Nie J; Jiao B Proc Natl Acad Sci U S A; 2018 Apr; 115(15):E3426-E3435. PubMed ID: 29581274 [TBL] [Abstract][Full Text] [Related]
38. Autoregulatory circuit of human rpL3 expression requires hnRNP H1, NPM and KHSRP. Russo A; Catillo M; Esposito D; Briata P; Pietropaolo C; Russo G Nucleic Acids Res; 2011 Sep; 39(17):7576-85. PubMed ID: 21705779 [TBL] [Abstract][Full Text] [Related]
39. SRSF1 and hnRNP H antagonistically regulate splicing of COLQ exon 16 in a congenital myasthenic syndrome. Rahman MA; Azuma Y; Nasrin F; Takeda J; Nazim M; Bin Ahsan K; Masuda A; Engel AG; Ohno K Sci Rep; 2015 Aug; 5():13208. PubMed ID: 26282582 [TBL] [Abstract][Full Text] [Related]
40. SRSF3/AMOTL1 splicing axis promotes the tumorigenesis of nasopharyngeal carcinoma through regulating the nucleus translocation of YAP1. Xu XC; Jiang JX; Zhou YQ; He S; Liu Y; Li YQ; Wei PP; Bei JX; Sun J; Luo CL Cell Death Dis; 2023 Aug; 14(8):511. PubMed ID: 37558679 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]